Buprenodale Vet. 0,3 mg/ml injektionsvæske, opløsning Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenodale vet. 0,3 mg/ml injektionsvæske, opløsning

dechra regulatory b.v. - buprenorphinhydrochlorid - injektionsvæske, opløsning - 0,3 mg/ml

Recarbrio Европейский союз - датский - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - imipenem, monohydrat, cilastatin natrium, relebactam monohydrat - gram-negative bakterie-infektioner - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 og 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..